Phase III study of bolus 5-fluoruracil (5-FU)/ folic acid (FA) (Mayo) vs. weekly high dose 24 h5-FU infusion/FA + oxaliplatin (OXA) in advanced colorectal cancer (ACRC). - Grothey,A.; Deschler,B.; Kroening,H. (Proc Am Soc Clin Oncol, 2002)